Related Experiment Video
Updated: Jul 18, 2025

04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.4K
Circ_0088212 Targeting miR-576-5p/FKBP1A Axis Inhibits Osteosarcoma Progression
1Joint Sugery, Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
Annals of Clinical and Laboratory Science
|August 25, 2023
Summary
Circular RNA circ_0088212 inhibits osteosarcoma progression by regulating the miR-576-5p/FKBP1A axis. Overexpression of circ_0088212 suppressed tumor growth, proliferation, and migration while enhancing apoptosis in osteosarcoma cells.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Circular RNAs (circRNAs) are key gene expression regulators.
- The specific role of circRNAs in osteosarcoma (OS) requires further elucidation.
Purpose of the Study:
- To investigate the function of circ_0088212 in osteosarcoma (OS).
Main Methods:
- Quantification of circ_0088212, miR-576-5p, and FKBP1A via qRT-PCR.
- Cellular function assays (proliferation, migration, apoptosis) and in vivo xenograft experiments.
- Western blotting for apoptosis-related proteins (Bcl-2, Bax) and dual-luciferase/RNA immunoprecipitation assays to confirm molecular interactions.
Main Results:
- circ_0088212 expression was downregulated in OS cells and tissues.
- Overexpression of circ_0088212 inhibited OS cell proliferation and migration, and increased apoptosis.
- circ_0088212 overexpression suppressed tumor growth in vivo, mediated by the miR-576-5p/FKBP1A axis.
Conclusions:
- circ_0088212 acts as a tumor suppressor in osteosarcoma.
- The miR-576-5p/FKBP1A axis is a key downstream pathway regulated by circ_0088212 in OS.
- circ_0088212 holds potential as a therapeutic target for osteosarcoma.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

